Skip to content

Effect of mini-low carbohydrate diet on glucose metabolism in patients with type 2 diabetes: open-label randomized controlled study

Effect of mini-low carbohydrate diet on glucose metabolism in patients with type 2 diabetes: open-label randomized controlled study - Effect of mini-low carbohydrate diet on glucose metabolism in patients with type 2 diabetes (EMILY Study)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012894
Enrollment
50
Registered
2014-01-20
Start date
2014-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2diabetes mellitus

Interventions

Moderate diet group A nationally registered dietitian guides a calorie-restricted diet of 25-30kcal/IBW day using a food exchange list.Periodic guidance is repeated during the 3months study period.

Sponsors

Yokohama City University Graduate School of Medicine Department of Endocrinology and Metabolism
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with type 2 diabetes. 2. Age more than 20 3. Under treatment with no antidiabetic agents, or with oral hypoglycemic drugs. 4. Patients with Hb1c less than 8.5% at entry.

Exclusion criteria

Exclusion criteria: 1. Complication by stage 3A or more severe diabetic nephropathy, or stage 3 or more severe chronic kidney disease(CKD)not associated with diabetes. 2. Malignant or acute disease 3. Severe liver disease 4. Decreased pancreatic function due to chronic pancreatitis 5. Hyperthyroidism 6. Adrenal insufficiency 7. Under steroid treatment 8. Patients judged to have difficulty in performing diabetics on his/her own due to dementia etc. 9. Other patients judged unsuitable by the attending physician.

Design outcomes

Primary

MeasureTime frame
Change in HbA1c

Secondary

MeasureTime frame
1. Change in fasting plasma glucose,1,5-Anhydroglucitol,glycated albumin,fasting plasma insulin 2. Change in body weight,waist circumference,body composition and basal energy expenditure. 3. Change in Lipid profile(LDL-C,HDL-C,TG) 4. Level of performance of dietary management(intake energy and nutrition survey) 5. Level of satisfaction with therapy,quality of life(questionary survey)

Countries

Japan

Contacts

Public ContactMasayo Kimura

Yokohama City University Graduate School of Medicine Department of Endocrinology and Metabolism

masayo59@yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026